Individual generic drug information

minoxidil

Reference monograph

Part of registered formulation

MINOXIDIL

Reference record: Minoxidil
Source: BNF 80 (2020–2021)
Printed source pages: 1363, 1364
Age groups indexed: 1

Individual active ingredientSource records are displayed separately

Some source sections could not be separated reliably in the extraction. Review the printed source pages when a field is missing or incomplete.

Overview

Extracted information for Minoxidil only.

Indications And Dose

REGAINE ® FOR MEN EXTRA STRENGTH FOAM Androgenetic alopecia ▶TO THE SKIN ▶Adult: Apply 0.5 capful twice daily, to be applied to the affected areas of scalp; discontinue if no improvement after 16 weeks REGAINE ® FOR MEN EXTRA STRENGTH SOLUTION Androgenetic alopecia ▶TO THE SKIN ▶Adult: Apply 1 mL twice daily, to be applied to the affected areas of scalp; discontinue if no improvement after 1 year REGAINE ® FOR WOMEN REGULAR STRENGTH Androgenetic alopecia ▶TO THE SKIN ▶Adult: Apply 1 mL twice daily, to be applied to the affected areas of scalp; discontinue if no improvement after 1 year

Source page 1363

Contra Indications

Phaeochromocytoma

Source page 1363

Cautions

Avoid contact with broken, infected, shaved, or inﬂamed skin. avoid contact with eyes. avoid contact with mouth. avoid contact with mucous membranes. avoid inhalation of spray mist. avoid occlusive dressings

Source pages 1363, 1364

Safety

Extracted information for Minoxidil only.

Interactions

→Appendix 1: minoxidil

Source page 1364

Side Effects

▶Common or very common Hair changes ▶Uncommon Hypotension SIDE-EFFECTS, FURTHER INFORMATION When used topically systemic effects unlikely; only about 1–2% absorbed (greater absorption may occur with use on inﬂamed skin).

Source page 1364

Pregnancy

Avoid—possible toxicity including reduced placental perfusion. Neonatal hirsutism reported.

Source page 1364

Breast Feeding

Present in milk but not known to be harmful.

Source page 1364

Dose and formulations

Extracted information for Minoxidil only.

Medicinal Forms

There can be variation in the licensing of Skin different medicines containing the same drug. Liquid CAUTIONARY AND ADVISORY LABELS 15 EXCIPIENTS: May contain Propylene glycol ▶Regaine (McNeil Products Ltd, Johnson & Johnson Ltd) Minoxidil 20 mg per 1 ml Regaine for Women Regular Strength 2% solution | 60 ml G £15.43 Minoxidil 50 mg per 1 ml Regaine for Men Extra Strength 5% scalp solution | 60 ml G £21.63 | 180 ml G £43.28 Foam CAUTIONARY AND ADVISORY LABELS 15 EXCIPIENTS: May contain Butylated hydroxytoluene, cetostearyl alcohol (including cetyl and stearyl alcohol), polysorbates ▶Regaine (McNeil Products Ltd) Minoxidil 50 mg per 1 gram Regaine for Men Extra Strength 5% scalp foam | 60 gram G £23.33 DT = £23.33 | 180 gram G £50.01 DT = £50.01 7.2 Hirsutism Other drugs used for Hirsutism Co-cyprindiol, p. 1335 ANTIPROTOZOALS

Source page 1364

Clinical care

Extracted information for Minoxidil only.

Patient And Carer Advice

Ensure hair and scalp dry before application. Patients and their carers should be advised to wash hands after application of liquid or foam.

Source page 1364

Dose text by age group

Filter the extracted dose blocks for this individual drug.

Adults

First line only; read the complete Indications and dose section above.

Apply 0.5 capful twice daily, to be applied to the

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 1363

Adults

First line only; read the complete Indications and dose section above.

Apply 1 mL twice daily, to be applied to the

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 1363

Adults

First line only; read the complete Indications and dose section above.

Apply 1 mL twice daily, to be applied to the

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 1363

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.

Individual generic drug information

minoxidil

Reference monograph

Part of registered formulation

MINOXIDIL

Reference record: Minoxidil
Source: BNF 80 (2020–2021)
Printed source pages: 1363, 1364
Age groups indexed: 1

Individual active ingredientSource records are displayed separately

Some source sections could not be separated reliably in the extraction. Review the printed source pages when a field is missing or incomplete.

Overview

Extracted information for Minoxidil only.

Indications And Dose

Source page 1363

Contra Indications

Phaeochromocytoma

Source page 1363

Cautions

Source pages 1363, 1364

Safety

Extracted information for Minoxidil only.

Interactions

→Appendix 1: minoxidil

Source page 1364

Side Effects

Source page 1364

Pregnancy

Avoid—possible toxicity including reduced placental perfusion. Neonatal hirsutism reported.

Source page 1364

Breast Feeding

Present in milk but not known to be harmful.

Source page 1364

Dose and formulations

Extracted information for Minoxidil only.

Medicinal Forms

Source page 1364

Clinical care

Extracted information for Minoxidil only.

Patient And Carer Advice

Ensure hair and scalp dry before application. Patients and their carers should be advised to wash hands after application of liquid or foam.

Source page 1364

Dose text by age group

Filter the extracted dose blocks for this individual drug.

Adults

First line only; read the complete Indications and dose section above.

Apply 0.5 capful twice daily, to be applied to the

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 1363

Adults

First line only; read the complete Indications and dose section above.

Apply 1 mL twice daily, to be applied to the

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 1363

Adults

First line only; read the complete Indications and dose section above.

Apply 1 mL twice daily, to be applied to the

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 1363

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.